The drug [Humira] is currently approved for use in reducing the signs and symptoms of rheumatoid arthritis.
In addition to RA and ulcerative colitis (the new indication), Humira is also FDA-approved for psoriatic arthritis, JIA, ankylosing spondylitis, plaque psoriasis, and Crohn’s disease. That’s why it’s the world’s largest-selling drug.